Synonyms
- Interstitial Cell-stimulating Hormone
Special Instructions
This test may exhibit interference when sample is collected from a person who is consuming a supplement with a high dose of biotin (also termed as vitamin B7 or B8, vitamin H, or coenzyme R). It is recommended to ask all patients who may be indicated for this test about biotin supplementation. Patients should be cautioned to stop biotin consumption at least 72 hours prior to the collection of a sample.
Expected Turnaround Time
Within 1 day
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Related Information
Related Documents
Specimen Requirements
Specimen
Serum (preferred) or plasma
Volume
1 mL
Minimum Volume
0.7 mL (Note: This volume does not allow for repeat testing.)
Container
Red-top tube, gel-barrier tube, or green-top (lithium heparin) tube. Do not use oxalate, EDTA, or citrate plasma.
Collection
If a red-top tube or plasma is used, transfer separated serum or plasma to a plastic transport tube.
Storage Instructions
Room temperature
Stability Requirements
Temperature | Period |
|---|---|
Room temperature | 14 days |
Refrigerated | 14 days |
Frozen | 14 days |
Freeze/thaw cycles | Stable x3 |
Test Details
Use
The primary clinical use of LH measurement is in evaluating the normalcy of hypothalamic-pituitary-gonadal axis. Measurement of serum gonadotropin levels will allow for distinguishing between primary gonadal failure and deficient gonadal stimulation. LH measurement may also be of clinical importance because growth hormone and LH are frequently the first hormones to be affected by pituitary disease. The serum analysis of LH has also been found to be very useful in the diagnosis and treatment of infertility in women.
Limitations
Secretion of both LH and FSH are pulsatile, in response to the normal intermittent release of gonadotropin-releasing hormone (GnRH). In addition, in females, both FSH and LH vary over the course of the menstrual cycle, with peaks at time of ovulation. Thus, interpretation of a single determination may be difficult. It has been suggested that samples be obtained at 15- to 30-minute intervals and equal volumes of serum be pooled to decrease the effect of pulsatile secretion.
As with all tests containing monoclonal mouse antibodies, erroneous findings may be obtained from samples taken from patients who have been treated with monoclonal mouse antibodies or who have received them for diagnostic purposes.1 In rare cases, interference due to extremely high titers of antibodies to streptavidin and ruthenium can occur.1 The test contains additives, which minimize these effects.
Methodology
Electrochemiluminescence immunoassay (ECLIA)
Reference Interval
See table.
Pediatric (Male and Female) (mIU/mL) | ||
|---|---|---|
<24 h | <0.2−1.0 | |
1 d | <0.2−0.8 | |
2 d | <0.2−0.6 | |
3 d | <0.2−2.7 | |
4 d | <0.2−1.7 | |
5 d | <0.2−3.1 | |
6 d | 0.4−6.4 | |
7 d | <0.2−5.6 | |
8 to 30 d | <0.2−7.8 | |
Age | Pediatric (Male) | Pediatric (Female) |
1 to 12 m | <0.2−0.4 | <0.2−0.4 |
1 to 4 y | <0.2−1.3 | <0.2−0.5 |
5 to 9 y | <0.2-1.4 | <0.2-3.1 |
10 to 12 y | <0.2−7.8 | <0.2−11.9 |
13 to 16 y | 1.3−9.8 | 0.5−41.7 |
Adult Male (mIU/mL): 1.7−8.6 | ||
Adult Female (mIU/mL) | ||
follicular | 2.4−12.6 | |
ovulation | 14.0−95.6 | |
luteal | 1.0−11.4 | |
postmenopausal | 7.7−58.5 | |
Additional Information
LH (luteinizing hormone), together with FSH (follicle-stimulating hormone), belongs to the gonadotropin family. LH and FSH regulate and stimulate the growth and function of the gonads (ovaries and testes) synergistically.2-4 Like FSH, TSH, and hCG, LH is a glycoprotein consisting of two subunits (α- and β-chains). This proteohormone, which consists of 121 amino acids3 and three sugar chains, has a molecular weight of 29,500 daltons.4
In women, the gonadotropins act within the hypothalamus-pituitary-ovary regulating circuit to control the menstrual cycle.5,6 LH and FSH are released in pulses from the gonadotropic cells of the anterior pituitary and pass via the bloodstream to the ovaries. Here the gonadotropins stimulate the growth and maturation of the follicle and hence the biosynthesis of estrogens and progesterones. The highest LH-concentrations occur during the midcycle peak and induce ovulation and formation of the corpus luteum, the principal secretion product of which is progesterone.
Determination of LH concentration is used in the elucidation of dysfunctions within the hypothalamus-pituitary-gonads system. In the Leydig cells of the testes, LH stimulates the production of testosterone.
The determination of LH in conjunction with FSH is utilized for the following indications: congenital diseases with chromosome aberrations (eg, Turner syndrome), polycystic ovaries (PCO), clarifying the causes of amenorrhea, menopausal syndrome, and suspected Leydig cell insufficiency.2,5,6
Footnotes
1. LH on Elecsys 1010/2010 and Modular Analytics E170. [Package insert]. 2007-03, V 14, Indianapolis, Ind: Roche Diagnostics; 2007.
2. Beastall GH, Ferguson KM, O'Reilly DS, Seth J, Sheridan B. Assays for follicle stimulating hormone and luteinizing hormone: Guidelines for the provision of a clinical biochemistry service. Ann Clin Biochem. 1987 May; 24(Pt 3):246-262. 3111341
3. Collip JB. The William Henry Welch Lectures: Some recent advances in the physiology of the anterior pituitary. 1934. Mt Sinai J Med. 1999 Oct-Nov; 66(5-6):342,343-364. 10618738
4. Johnson MR, Carter G, Grint C, Lightman SL. Relationship between ovarian steroids, gonadotropins and relaxin during the menstrual cycle. Acta Endocrinol (Copenh). 1993 Aug; 129(2):121-125. 8372595
5. Runnebaum B, Rabe T. Gynäkologische Endokrinologie und Fortpflanzungsmedizin. Springer Verlag; 1994. Band 1: 17, 202-5, 252-3; Band 2: 350, 360-2. ISBN 3-540-57345-3, ISBN 3-540-57347-X.
6. Scott MG, Ladenson JH, Green ED, Gast MJ. Hormonal evaluation of female infertility and reproductive disorders. Clin Chem. 1989 Apr; 35(4):620-630. 2522836
References
Findling JW, Tyrrell JB. Anterior pituitary and somatomedins: I. Anterior pituitary. In: Greenspan FS, Forsham PH, eds. Basic and Clinical Endocrinology. Los Altos, Calif: Lange Medical Publications;1983:38-88.
Kossoy LR, Hill GA, Parker RA, et al. Luteinizing hormone and ovulation timing in a therapeutic donor insemination program using frozen semen. Am J Obstet Gynecol. 1989 May; 160(5 Pt 1):1169-1172. 2729391
Nippoldt TB, Reame NE, Kelch RP, Marshall JC. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle. J Clin Endocrinol Metab. 1989 Jul; 69(1):67-76. 2499593
LOINC® Map
| Order Code | Order Code Name | Order Loinc | Result Code | Result Code Name | UofM | Result LOINC |
|---|---|---|---|---|---|---|
| 004283 | Luteinizing Hormone(LH) | 10501-5 | 004290 | LH | mIU/mL | 10501-5 |
© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.
CPT Statement/Profile Statement
The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf